CA - Knight Therapeutics Inc. (KHTRF) Q1 2025 Earnings Call Transcript
2025-05-11 03:30:45 ET
Knight Therapeutics Inc. (KHTRF)
Q1 2025 Earnings Conference Call
May 8, 2025 8:30 AM ET
Company Participants
Samira Sakhia – President and Chief Executive Officer
Arvind Utchanah – Chief Financial Officer
Conference Call Participants
Michael Freeman – Raymond James
Presentation
Operator
Good morning, ladies and gentlemen. My name is Elle [ph], and I will be your operator today. Welcome to Knight Therapeutics First Quarter 2025 Results Conference Call. Before turning the call over to Samira Sakhia, President and CEO of Knight, listeners are reminded that portions of today's discussion may, by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements.
The company considers the assumptions on which these forward-looking statements are based to be reasonable at the time they were prepared, but cautions that these assumptions regarding the future events, many of which are beyond the control of the company and its subsidiaries, may ultimately prove to be incorrect. The company disclaims any intention or obligation to update or revise any forward-looking statements, whether a result of new information, future events, except as required by law....
Knight Therapeutics Inc. (KHTRF) Q1 2025 Earnings Call Transcript